The document discusses an in silico primary screening of a drug database using a pharmacophore model in ZINCPharmer. The procedure involved running the pharmacophore model in ZINCPharmer, converting results to different file formats, uploading them to a high performance computer, and converting the file formats again. The results identified 681 hits in 1.204 seconds that fulfilled the requirements of the pharmacophore model. The screening helped precisely select compounds for further screening and could aid in drug discovery.
2. Introduction
What is In-Silico?
Merriam-Webster definition: in or on a computer :
done or produced by using computer software or
simulation.
What is ZINCPharmer?
is an online interface for searching the
purchasable compounds of the ZINC database
using the Pharmer pharmacophore search
technology
3. Primary screening: Filtering of drug database (Ligand
Scout)
Primary screening: Filtering of drug database
Objective: Identification of compounds that
fulfill requirements of pharmacophore model
generation.
What is needed:
1. Pharmacophore Model
2. Access to ZINCPharmer
3. Drug Database
4. Procedure
1. Run the Pharmacophore Model in
ZINCPharmer
2. Conversion of results from .sdf to .mol2
3. Upload the Results to server (NanoBio) in
UPR-Hight Performance Computer Facility
(HPCf) using CyberDuck.
4. Connect to NanoBio in UPR-High
Performance Computer Facility (HPCf)
5. Conversion of Results
11. Conclusions
At the end of the filtering procedures,
compounds that would possibly fulfill the
pharmacophore model requirements were
identified
681 hits in 1.204 seconds were identified as a
result of the first screening
Each screening served as a filtrate to each of the
compounds that were selected
It is very useful because of the precise selection
of compounds to be used on a second screening
process
12. Conclusions
To identify specific chemical groups would
lead to a more precise search of potential lead
compounds
Screening processes help scientists on the
discovery of new drugs, and therapies against
several diseases related to drug effects on the
human body